NeuroPong - Structured Table Tennis Program Improves Parkinson’s Motor Function by 18%

Parkinson’s disease has no cure. Medications manage symptoms but do not halt progression. Exercise is the only established disease-modifying intervention. Now a 12-week structured table tennis program has produced significant improvements in motor function, balance, walking endurance, and depression in a clinical trial.

The Clinical Trial

Barbera and colleagues at the University of Colorado School of Medicine and the International Table Tennis Federation Foundation conducted a single-arm pilot study of 30 Parkinson’s patients. Participants completed 12 weeks of twice-weekly, 2-hour table tennis sessions under a structured protocol called NeuroPong.

The study measured standard clinical outcomes including the Movement Disorders Society-Unified Parkinson’s Disease Rating Scale Part III (MDS-UPDRS III), which rates motor symptoms on a 0 to 132 scale. Lower scores indicate better function.

Key Findings

The results were statistically significant across multiple domains:

Motor function: MDS-UPDRS Part III scores improved by a mean of 5.73 points, a reduction in symptom severity. This corresponds to an approximately 18% improvement from typical baseline scores. The finding was highly significant (p = 0.0014).

Balance: Berg Balance Scale scores improved by a mean of 3.08 points (p < 0.0001). The BBS measures 14 balance tasks with a maximum score of 56. A 3-point improvement is clinically meaningful.

Functional mobility: Timed Up and Go test times decreased by a mean of 1.04 seconds (p = 0.0032). Faster times indicate better mobility and lower fall risk.

Walking endurance: Six-Minute Walk Test distance increased by a mean of 66.77 meters (p < 0.0001). This represents substantial improvement in cardiovascular and walking capacity.

Depression: Self-reported depression scores on the Hospital Anxiety and Depression Scale decreased by a mean of 1.12 points (p = 0.0129).

Feasibility and Safety

The study protocol was highly feasible. Attendance averaged approximately 90% across the 12-week program. Of 30 enrolled participants, 26 completed the study, representing an 86.7% completion rate. No adverse events were reported.

High adherence is a critical differentiator. Many exercise interventions for Parkinson’s suffer from low participation rates. The 90% attendance in this structured table tennis program suggests it is engaging and sustainable.

Why Table Tennis for Parkinson’s?

The NeuroPong protocol likely works because table tennis integrates multiple neural systems simultaneously:

Visuospatial processing: Tracking a small, fast-moving ball activates visual attention and spatial mapping systems.

Anticipatory motor planning: Players must initiate strokes before the ball arrives, training predictive motor control.

Dynamic postural control: Shifting weight, lunging, and recovering balance challenges the vestibular and proprioceptive systems.

Cognitive engagement: Table tennis requires continuous attention, decision-making, and working memory. Parkinson’s affects cognition alongside motor function.

This combination addresses both the motor and non-motor symptoms of Parkinson’s disease in a single activity.

Comparison to Existing Evidence

The 2026 meta-analysis by Li and colleagues in Healthcare found that table tennis improves balance in Parkinson’s patients with a large effect size (SMD = 0.78) across 14 randomized controlled trials. The NeuroPong study’s 3.08-point improvement on the Berg Balance Scale aligns with this finding.

Similarly, a 2025 clinical review by Khalid and Khalid in Cureus confirmed that table tennis benefits motor control, cognitive function, and psychosocial well-being in Parkinson’s patients. The NeuroPong trial adds specific, quantitative data to this body of evidence.

What Makes NeuroPong Different

Most previous studies investigated table tennis as an unstructured recreational activity. NeuroPong is a structured, standardized protocol developed by neurologists and table tennis experts. The twice-weekly, 2-hour format provides sufficient dose and intensity to drive physiological adaptation.

The program’s branding and structure may also enhance adherence. Participants know they are in a research-backed therapeutic intervention, not casual play.

Limitations and Future Research

This was a single-arm pilot study without a control group. The 26 participants who completed the trial cannot establish causality definitively. However, the magnitude and consistency of improvements across multiple outcome measures strengthen the findings.

Larger randomized controlled trials are warranted. The study authors note that a full-scale RCT is the logical next step.

Clinical Implications

For clinicians working with Parkinson’s patients, NeuroPong offers a structured, evidence-based option that addresses both motor and non-motor symptoms simultaneously. The safety profile and high adherence make it attractive for real-world implementation.

For patients, table tennis provides engaging, social, and cognitively stimulating exercise that may slow functional decline. Unlike medication, it has no side effects and addresses multiple symptoms concurrently.

The Bottom Line

Parkinson’s patients in the NeuroPong trial experienced statistically significant improvements in motor function, balance, walking endurance, and depression after 12 weeks of structured table tennis. The 90% attendance rate and zero adverse events suggest the protocol is feasible and safe.

Table tennis is not a cure for Parkinson’s disease. But as an adjunct therapy, it targets the disease from multiple angles: motor control, balance, gait, cognition, and mood. The emerging evidence suggests it should be part of the standard therapeutic toolkit.

Sources:

• Barbera A, Woodward M, Buard I, Sillau S, Montes RO, Feuerstein J. “A Pilot Table Tennis-Based Neurorehabilitation Program to Improve Parkinson’s Disease Symptoms.” NeuroRehabilitation. 2026 Jul 15. DOI 10.1177/10538135261468787.
• Li H, Ahn H, Shin M. “Effects of table tennis on balance and cognitive function: a meta-analysis of 14 randomized controlled trials.” Healthcare (Basel). 2026;14(5):675.
• Khalid A, Khalid R. “Table tennis for Parkinson’s disease: motor, cognitive, and psychosocial benefits.” Cureus. 2025;17(11):e96383.